CCL5 and COVID-19: also demonstrated that elevated levels of PF4 and RANTES, which were demonstrated to trigger NETosis, were detected in plasma from COVID-19 patients and COVID-19 plasma-induced NET formation was inhibited by neonatal NET-Inhibitory Factor (nNIF), indicating that NETs contributed to immunothrombosis in COVID-19 patients (165).